Analytical Data
-
Gene name
EMR2
- Application
-
Alternative Names
CD312; EGF-like module receptor 2
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9UHX3
-
Expression Region
Asn347~Ser509
-
Molecular Weight
21kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EMR2, or EGF-like module containing mucin-like hormone receptor-like 2, is a member of the epidermal growth factor receptor (EGFR) family and has been identified as a key player in various biological processes, including immune response and cellular signaling. Its unique structure allows it to interact with a range of proteins and ligands, making it a critical component in the modulation of cell adhesion and migration. Research into EMR2 has gained momentum due to its potential implications in cancer biology, inflammation, and developmental disorders. The recombinant protein form of EMR2 enables researchers to study its functional characteristics and interactions in vitro and in vivo, facilitating a deeper understanding of its role in health and disease. This research has the potential to unveil novel therapeutic targets and strategies for modulating EMR2-related pathways, contributing to the advancement of biomedical science and improving outcomes in conditions associated with dysregulated EMR2 expression or function. As such, the study of EMR2 recombinant proteins is crucial for elucidating the complex mechanisms of cellular communication and the development of innovative approaches to treat relevant pathologies.
